These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37422150)

  • 1. Sex-Dependent Differences in Cholestasis: Why Estrogen Signaling May Be a Key Pathophysiological Driver.
    Ismail A; Kennedy L; Francis H
    Am J Pathol; 2023 Oct; 193(10):1355-1362. PubMed ID: 37422150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice.
    Li X; Liu R; Yang J; Sun L; Zhang L; Jiang Z; Puri P; Gurley EC; Lai G; Tang Y; Huang Z; Pandak WM; Hylemon PB; Zhou H
    Hepatology; 2017 Sep; 66(3):869-884. PubMed ID: 28271527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
    Degiorgio D; Crosignani A; Colombo C; Bordo D; Zuin M; Vassallo E; Syrén ML; Coviello DA; Battezzati PM
    J Gastroenterol; 2016 Mar; 51(3):271-80. PubMed ID: 26324191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients.
    Kruk B; Milkiewicz M; Raszeja-Wyszomirska J; Milkiewicz P; Krawczyk M
    Orphanet J Rare Dis; 2022 Nov; 17(1):419. PubMed ID: 36397154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of cholestatic disease in 2017.
    de Vries E; Beuers U
    Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis].
    Fejfar T; Vaňásek T; Hůlek P
    Vnitr Lek; 2020; 66(5):287-300. PubMed ID: 32942866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic cholestatic diseases.
    Poupon R; Chazouillères O; Poupon RE
    J Hepatol; 2000; 32(1 Suppl):129-40. PubMed ID: 10728800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese and copper levels in patients with primary biliary cirrhosis and primary sclerosing cholangitis.
    Dastych M; Husová L; Aiglová K; Fejfar T; Dastych M
    Scand J Clin Lab Invest; 2021 Apr; 81(2):116-120. PubMed ID: 33428478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholestatic liver diseases].
    Grimm D; Thimme R
    Ther Umsch; 2011 Apr; 68(4):195-9. PubMed ID: 21452140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
    Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
    Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic determinants of acquired cholestasis: a systems biology approach.
    Sookoian S; Pirola CJ
    Front Biosci (Landmark Ed); 2012 Jan; 17(1):206-20. PubMed ID: 22201739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis.
    Lammert C; Juran BD; Schlicht E; Xie X; Atkinson EJ; de Andrade M; Lazaridis KN
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1562-8. PubMed ID: 24440215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomic analysis of cholestatic liver damage in mice.
    Yang R; Zhao Q; Hu DD; Xiao XR; Huang JF; Li F
    Food Chem Toxicol; 2018 Oct; 120():253-260. PubMed ID: 30009888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease.
    Duengelhoef P; Hartl J; Rüther D; Steinmann S; Brehm TT; Weltzsch JP; Glaser F; Schaub GM; Sterneck M; Sebode M; Weiler-Normann C; Addo MM; Lütgehetmann M; Haag F; Schramm C; Schulze Zur Wiesch J; Lohse AW
    United European Gastroenterol J; 2022 Apr; 10(3):319-329. PubMed ID: 35289983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases.
    Walker DI; Juran BD; Cheung AC; Schlicht EM; Liang Y; Niedzwiecki M; LaRusso NF; Gores GJ; Jones DP; Miller GW; Lazaridis KN
    Hepatol Commun; 2022 May; 6(5):965-979. PubMed ID: 34825528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gut microbial influence on cholestatic liver disease.
    Kummen M; Hov JR
    Liver Int; 2019 Jul; 39(7):1186-1196. PubMed ID: 31125502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.
    Sarcognato S; Sacchi D; Grillo F; Cazzagon N; Fabris L; Cadamuro M; Cataldo I; Covelli C; Mangia A; Guido M
    Pathologica; 2021 Jun; 113(3):170-184. PubMed ID: 34294935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Aspects in the Management of Cholestatic Liver Diseases.
    Chazouillères O
    Dig Dis; 2016; 34(4):340-6. PubMed ID: 27170387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
    Mattner J
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.